• BlackRock disclosed a stake in Pharming Group dated May 25, 2026, covering 17,748,233 shares held directly or indirectly.
• The filing also reported 23,605,045 voting rights, including 2,784,030 potential voting rights tied to physical settlement instruments.
• Largest reported blocks included 12,431,867 shares via BlackRock Fund Advisors, 4,615,813 shares via BlackRock Institutional Trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief on May 25, 2026, and is solely responsible for the information contained therein.